Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licartin plus radiofrequency ablation for prevention of hepatocellular carcinoma recurrence
ChiCTR-TRC-10000837Phase 4Completed
- Sponsor
- Air Force Medical University
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of licofelone in hepatocellular carcinoma (HCC) (2 arms), sponsored by Air Force Medical University. Primary endpoints: Overall tumor recurrence, Time to tumor recurrence and 1 more. Started Apr 2010; status: completed.
02
Drugs
licofelone
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-TRC-10000837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000837.